We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

OmniComm Systems Announces New Release of TrialOne
Product News

OmniComm Systems Announces New Release of TrialOne

OmniComm Systems Announces New Release of TrialOne
Product News

OmniComm Systems Announces New Release of TrialOne

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "OmniComm Systems Announces New Release of TrialOne"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

OmniComm Systems, Inc. a leading global provider of clinical data management solutions for clinical trials, has announced the general availability of TrialOne version 4.3. TrialOne is a browser-based, mobile, clinic automation solution designed specifically for early-phase research that facilitates subject recruitment, source data capture, sample tracking, data management and reporting. TrialOne offers time-based data entry and automates many data collection activities via its ability to both print and scan barcodes, as well as to integrate directly with medical monitoring and laboratory equipment. Furthermore, TrialOne's import and export features provide integration with laboratory information management systems for lab orders and results processing.

TrialOne version 4.3 includes numerous productivity and functionality enhancements that drive efficiencies and reduces costs through faster volunteer recruitment, flexible screening questionnaires, direct data capture, work flow automation and modern data processing.

Enhancements to TrialOne include the following:

    •    Comprehensive integration with bedside patient monitoring, telemetry and clinical devices with enhanced ability to send electrocardiography (ECG) orders to devices such as Mortara Surveyor™ Central System, Seca scales, and Sartorius laboratory balances.
    •    Enable open-label clinical study design allowing researchers and participants to know which treatment is being administered.
    •    Ability to read ECG tracings in real-time enabling clinic staff to effectively respond to research participants in a timely fashion.
    •    Study teams receive electronic notification alerts of research participant's adverse experiences allowing them to take appropriate clinical action and medical intervention.
    •    Enhancements in handling treatment blinding allows researchers to effectively track drugs per research participant in adherence to clinical plan and dosages ensuring adherence to clinical protocols where multiple drugs are ordered.
    •    TrialOne now supports open-label (no blinding), single-blinding (participant blinded), double-blinding (floor staff blinded), and triple-blinding (data extract blinded).

"TrialOne continues to set the standard for the automation of early phase clinics," stated Randy Smith, OmniComm's CTO and TrialOne Group Executive Sponsor. "The 4.3 release builds on our successful TrialOne suite providing a platform for future planned enhancements".